Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
- 23 January 2009
- journal article
- case report
- Published by Wiley in Clinical Genetics
- Vol. 75 (2), 141-149
- https://doi.org/10.1111/j.1399-0004.2008.01125.x
Abstract
Lynch syndrome or hereditary non‐polyposis colorectal cancer is caused by mutations of DNA mismatch repair (MMR) genes. The extracolonic tumour spectrum includes endometrial, ovarian, gastric, small bowel, pancreatic, hepatobiliary, brain, and urothelial neoplasms. Families were referred on the basis of clinical criteria. Tumour immunohistochemistry and microsatellite testing were performed. Appropriate patients underwent sequencing of relevant exons of the MMR genes. Proven and obligate mutation carriers and first‐degree relatives (FDRs) with a Lynch syndrome spectrum cancer were considered mutation carriers, as were a proportion of untested, unaffected FDRs based on the proportion of unaffected relatives testing positive in each age group. Kaplan–Meier analysis of risk to 70 years was calculated. One hundred and eighty‐four Lynch syndrome spectrum extracolonic cancers in 839 proven, obligate, or assumed mutation carriers were analysed. Cumulative risk for females of an extracolonic tumour is 47.4% (95% CI 43.9–50.8). The risk to males is 26.5% (95% CI 22.6–30.4). There was no reduction in gynaecological malignancies due to gynaecological screening (examination, transvaginal ultrasound scan, hysteroscopy and endometrial biopsy). Males have a higher risk of gastric cancer than females (p = 0.0003). Gastric cancer risk in those born after 1935 does not justify surveillance. These penetrance estimates have been corrected for ascertainment bias and are appropriate for those referred to a high‐risk clinic.Keywords
This publication has 28 references indexed in Scilit:
- Identification and Survival of Carriers of Mutations in DNA Mismatch-Repair Genes in Colon CancerNew England Journal of Medicine, 2006
- Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillanceGastroenterology, 2004
- Hereditary Colorectal CancerNew England Journal of Medicine, 2003
- MSH2 Mutation Carriers Are at Higher Risk of Cancer Than MLH1 Mutation Carriers: A Study of Hereditary Nonpolyposis Colorectal Cancer FamiliesJournal of Clinical Oncology, 2001
- New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆Gastroenterology, 1999
- Cancer risk in mutation carriers of DNA-mismatch-repair genesInternational Journal of Cancer, 1999
- Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancerJournal of Gastrointestinal Surgery, 1998
- Colorectal cancer risk in HNPCC families: Development during lifetime and in successive generationsInternational Journal of Cancer, 1997
- Cancer risk associated with germline DNA mismatch repair gene mutationsHuman Molecular Genetics, 1997
- Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated reviewCancer, 1996